Drugmaker Eli Lilly walks back 2024 forecast after 3Q earnings miss
AP Health Writer — Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations. The drugmaker on Wednesday chopped a few […]